COVID-19 Home Monitoring After Diagnosis and Health Care Utilization in an Integrated Health System.


Journal

JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500

Informations de publication

Date de publication:
05 2021
Historique:
received: 04 02 2021
accepted: 03 03 2021
entrez: 17 8 2022
pubmed: 6 5 2021
medline: 6 5 2021
Statut: epublish

Résumé

This cohort study examines health care utilization patterns for patients with COVID-19 who were enrolled vs not enrolled in a home monitoring program.

Identifiants

pubmed: 35977306
doi: 10.1001/jamahealthforum.2021.0333
pii: ald210002
pmc: PMC8796892
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e210333

Informations de copyright

Copyright 2021 Misra-Hebert AD et al. JAMA Health Forum.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosures: Dr Misra-Hebert reported grants from the Agency for Healthcare Research and Quality, National Heart Lung and Blood Institute, National Human Genome Research Institute, Novo Nordisk, Merck, and Boehringer Ingelheim Pharmaceuticals outside the submitted work. Dr Jehi receives funding from the National Institute of Neurological Disorders and Stroke and from the National Center for Advancing Translational Science outside the submitted work. Mr Milinovich receives grants from Novo Nordisk, Merck, Boehringer Ingelheim Pharmaceuticals, National Institute on Aging, and NFL Players Association outside the submitted work. Dr Kattan receives grant funding from Novo Nordisk, Merck, and Boehringer Ingelheim Pharmaceuticals and is a consultant for GlaxoSmithKline and RenalytixAI outside of the submitted work. No other disclosures were reported.

Références

J Gen Intern Med. 2020 Sep;35(9):2816-2817
pubmed: 32666485
Appl Clin Inform. 2020 Oct;11(5):792-801
pubmed: 33241547
Am J Epidemiol. 2019 Jan 1;188(1):250-257
pubmed: 30189042
J Gen Intern Med. 2021 Mar;36(3):722-729
pubmed: 33443699
Emerg Med J. 2021 Mar;38(3):229-231
pubmed: 33472870

Auteurs

Anita D Misra-Hebert (AD)

Healthcare Delivery and Implementation Science Center, Cleveland Clinic, Cleveland, Ohio.

Xinge Ji (X)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.

Lara Jehi (L)

Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.

Alex Milinovich (A)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.

Elizabeth R Pfoh (ER)

Center for Value-Based Care Research, Cleveland Clinic Community Care, Cleveland, Ohio.

Michael W Kattan (MW)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.

James B Young (JB)

Healthcare Delivery and Implementation Science Center, Cleveland Clinic, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH